Diabetes & NASH Discovery | InSphero

Advanced 3D models for metabolic disease research and drug efficacy testing

Our scientists have developed islet and liver disease models based on our innovative 3D cell-based technology platforms that closely mimic healthy and diseased human biology.  You can rely on our fully validated and standardized assay-ready 3D disease models and wide-range of certified applications to accelerate your diabetes and fibrosis/NASH drug discovery.

Find out how InSphero microtissues and services

can accelerate safety and efficacy testing of your drug.

Get Started